Previous reports have described that CD38 expression might identify CD4+ T-cell subsets with immunomodulatory properties [39]; thus, we hypothesize CD38 expression in T-cells from SLE patients can mediate disease development through regulatory activity. The gene discussed is CD4; the disease is systemic lupus erythematosus.